COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1894: Articles 18931-18940  | Next

The mechanism of SARS-CoV-2 nucleocapsid protein recognition by the human 14-3-3 proteins
Tugaeva, K. V., Hawkins, D. E. D. P., Smith, J. L. R., Bayfield, O. W., Ker, D.-S., Sysoev, A. A., Klychnikov, O. I., Antson, A. A., Sluchanko, N. N.
10.1101/2020.12.26.424450 — Posted: 2020-12-27
SARS-CoV-2 mutations among minks show reduced lethality and infectivity to humans
Konishi, T.
10.1101/2020.12.23.424267 — Posted: 2020-12-27
Disruption of nasal bacteria enhances protective immune responses to influenza A virus and SARS-CoV-2 infection in mice
Nagai, M., Moriyama, M., Ichinohe, T.
10.1101/2020.12.25.424300 — Posted: 2020-12-27
Salivary SARS-CoV-2 antigen rapid detection: a prospective cohort study
Basso, D., Aita, A., Padoan, A., Cosma, C., Navaglia, F., Moz, S., Contran, N., Zambon, C.-F., Cattelan, A. M., Plebani, M.
10.1101/2020.12.24.20248825 — Posted: 2020-12-27
S-variant SARS-CoV-2 is associated with significantly higher viral loads in samples tested by ThermoFisher TaqPath RT-PCR
Kidd, M., Richter, A., Best, A., Mirza, J., Percival, B., Mayhew, M., Megram, O., Ashford, F., White, T., Moles-Garcia, E., Crawford, L., Bosworth, A., Plant, T., McNally, A.
10.1101/2020.12.24.20248834 — Posted: 2020-12-27 Discussion: Onsite | Offsite
Quantifying the online news media coverage of the COVID-19 pandemic.
Krawczyk, K., Chelkowski, T., Mishra, S., Xifara, D., Gibert, B., Laydon, D. J., Flaxman, S., Mellan, T. A., Schwämmle, V., Röttger, R., Hadsund, J. T., Bhatt, S.
10.1101/2020.12.24.20248813 — Posted: 2020-12-27
Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England
Davies, N. G., Barnard, R. C., Jarvis, C. I., Kucharski, A. J., Munday, J. D., Pearson, C. A. B., Russell, T., Tully, D., Abbott, S., Gimma, A., Waites, W., Wong, K. L. M., van Zandvoort, K., CMMID COVID-19 Working Group, , Eggo, R. M., Funk, S., Jit, M., Atkins, K. E., Edmunds, W. J.
10.1101/2020.12.24.20248822 — Posted: 2020-12-26 Discussion: Offsite
Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact
Davis, H. E., Assaf, G. S., McCorkel, L., Wei, H., Low, R. J., Reem, Y., Redfield, S., Austin, J. P., Akrami, A.
10.1101/2020.12.24.20248802 — Posted: 2020-12-26 Discussion: Onsite | Offsite
Mental health, personality and lifetime psychedelic use during the COVID-19 pandemic
Cavanna, F., Pallavicini, C., Milano, V., Cuiule, J., Di Tella, R., Gonzalez, P., Tagliazucchi, E.
10.1101/2020.12.24.20248519 — Posted: 2020-12-26
Understanding Covid-19 misinformation and vaccine hesitancy in context: Findings from a qualitative study involving citizens in Bradford, UK
Lockyer, B., Islam, S., Rahman, A., Dickerson, J., Pickett, K., Sheldon, T., Wright, J., McEachan, R., Sheard, L.
10.1101/2020.12.22.20248259 — Posted: 2020-12-26 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).